不同治疗方式对ARR阳性高血压患者心血管疾病的影响
Rui Chen1, Hairong Hao1, Yuhong Dai1
1Department of Endocrinology and Metabolism, Huai'an Hospital Affiliated to Xuzhou Medical College, Huai'an, 223002, China.
概括
未经诊断的高血压患者具有高的阿尔多与素比率 (ARR) 面临风险. 在严重病例中,手术是有益的,而螺旋可能会增加某些患者的脑血管并发症.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 有关临床未诊断的高血压患者的预后的数据是有限的,他们具有阳性阿尔多与雷宁比率 (ARR).
- 原发性阿尔多斯顿症 (PA) 往往被诊断不足,影响患者的治疗结果.
研究的目的:
- 为了研究未被诊断的高血压患者的临床特征,ARR ≥3.8.
- 评估不同治疗策略 (手术,螺旋乳,控制) 对并发症的影响.
主要方法:
- 对135名未被诊断的高血压患者的回顾性分析,ARR≥3.8.
- 在手术,螺旋和对照组中比较临床特征和并发症率.
主要成果:
- 只有11.9%的ARR≥3.8的高血压患者被诊断为PA;血压遵守率为50.30%.
- 手术组的血液含量较低,阿尔多水平较高,以及脑血管并发症风险较低,与螺旋龙相比.
- 螺旋乳组的新脑血管并发症风险增加了9.520倍,特别是在ARR为3.8-5.7.7的患者中.
结论:
- 对于严重的过高阿尔多斯特和低血清症,手术是可行的选择,特别是当确认性测试是不可行的时.
- 在ARR为3.8-5.7的未被诊断的高血压患者中,螺旋龙治疗与脑血管并发症的风险增加有关.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
160
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
160
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Pathophysiology of Cardiac Performance
645
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
645


